Mercer Global Advisors
IONS icon

Mercer Global Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Mercer Global Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$473K Buy
6,296
+742
+13% +$58.6K ﹤0.01% 2032
2025
Q4 		$439K Buy
5,554
+1,807
+48% +$136K ﹤0.01% 1955
2025
Q3 		$245K Buy
+3,747
New +$183K ﹤0.01% 2238
2024
Q1 		– Sell
-4,676
Closed -$237K – 2094
2023
Q4 		$237K Sell
4,676
-420
-8% -$20.1K ﹤0.01% 1745
2023
Q3 		$231K Sell
5,096
-267
-5% -$11K ﹤0.01% 1692
2023
Q2 		$220K Buy
+5,363
New +$206K ﹤0.01% 1693
2022
Q3 		– Sell
-5,396
Closed -$200K – 1871
2022
Q2 		$200K Buy
+5,396
New +$203K ﹤0.01% 1636
2020
Q1 		– Sell
-3,449
Closed -$208K – 1174
2019
Q4 		$208K Sell
3,449
-893
-21% -$53.2K ﹤0.01% 1070
2019
Q3 		$260K Sell
4,342
-446
-9% -$29.1K 0.01% 938
2019
Q2 		$308K Buy
4,788
+1,749
+58% +$124K 0.01% 866
2019
Q1 		$247K Buy
+3,039
New +$196K 0.01% 906

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mercer Global Advisors's IONS Position: Q1 2026 in Review

Mercer Global Advisors increased its Ionis Pharmaceuticals (IONS) stake by 13% in Q1 2026, buying an estimated $58.6K and bringing the position to 6,296 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #2032.

Mercer Global Advisors first reported a position in IONS in Q1 2019 and has held it in 11 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Mercer Global Advisors held 6,296 shares of Ionis Pharmaceuticals worth $473K as of Q1 2026.
  • Mercer Global Advisors bought 742 Ionis Pharmaceuticals shares in Q1 2026, an estimated $58.6K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #2032 holding.
  • Mercer Global Advisors first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 11 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.